Author
Listed:
- Dimitra Kerdidani
(Biomedical Sciences Research Center Alexander Fleming
National and Kapodistrian University of Athens)
- Panagiotis Chouvardas
(Biomedical Sciences Research Center Alexander Fleming
University of Bern
University of Bern)
- Ares Rocanin Arjo
(Integrative Biology of Human Dendritic Cells and T Cells, Institute Curie)
- Ioanna Giopanou
(University of Patras, Rio)
- Giannoula Ntaliarda
(University of Patras, Rio)
- Yu Amanda Guo
(Genome Institute of Singapore, Agency for Science Technology and Research)
- Mary Tsikitis
(Biomedical Research Foundation of the Academy of Athens)
- Georgios Kazamias
(Evangelismos General Hospital)
- Konstantinos Potaris
(Sotiria General Hospital)
- Georgios T. Stathopoulos
(University of Patras, Rio
Ludwig-Maximilians University and Helmholtz Center Munich, Member of the German Center for Lung Research (DZL))
- Spyros Zakynthinos
(National and Kapodistrian University of Athens)
- Ioannis Kalomenidis
(National and Kapodistrian University of Athens)
- Vassili Soumelis
(Integrative Biology of Human Dendritic Cells and T Cells, Institute Curie)
- George Kollias
(Biomedical Sciences Research Center Alexander Fleming
National and Kapodistrian University of Athens)
- Maria Tsoumakidou
(Biomedical Sciences Research Center Alexander Fleming)
Abstract
Lung adenocarcinoma (LUAD)-derived Wnts increase cancer cell proliferative/stemness potential, but whether they impact the immune microenvironment is unknown. Here we show that LUAD cells use paracrine Wnt1 signaling to induce immune resistance. In TCGA, Wnt1 correlates strongly with tolerogenic genes. In another LUAD cohort, Wnt1 inversely associates with T cell abundance. Altering Wnt1 expression profoundly affects growth of murine lung adenocarcinomas and this is dependent on conventional dendritic cells (cDCs) and T cells. Mechanistically, Wnt1 leads to transcriptional silencing of CC/CXC chemokines in cDCs, T cell exclusion and cross-tolerance. Wnt-target genes are up-regulated in human intratumoral cDCs and decrease upon silencing Wnt1, accompanied by enhanced T cell cytotoxicity. siWnt1-nanoparticles given as single therapy or part of combinatorial immunotherapies act at both arms of the cancer-immune ecosystem to halt tumor growth. Collectively, our studies show that Wnt1 induces immunologically cold tumors through cDCs and highlight its immunotherapeutic targeting.
Suggested Citation
Dimitra Kerdidani & Panagiotis Chouvardas & Ares Rocanin Arjo & Ioanna Giopanou & Giannoula Ntaliarda & Yu Amanda Guo & Mary Tsikitis & Georgios Kazamias & Konstantinos Potaris & Georgios T. Stathopou, 2019.
"Wnt1 silences chemokine genes in dendritic cells and induces adaptive immune resistance in lung adenocarcinoma,"
Nature Communications, Nature, vol. 10(1), pages 1-16, December.
Handle:
RePEc:nat:natcom:v:10:y:2019:i:1:d:10.1038_s41467-019-09370-z
DOI: 10.1038/s41467-019-09370-z
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:10:y:2019:i:1:d:10.1038_s41467-019-09370-z. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.